During the past decade, Instituto Argentino de Diagnostico y Tratamiento conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Instituto Argentino de Diagnostico y Tratamiento" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Argentinian Intensive Care Society" with 1 trials sponsored, "Cytograft Tissue Engineering" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Instituto Argentino de Diagnostico y Tratamiento" are "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Atrial Fibrillation" (1 trials), "Breast Neoplasms" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials) and "Cardiac Arrhythmias" (1 trials). Many other conditions were trialed in "Instituto Argentino de Diagnostico y Tratamiento" in a lesser frequency.

Most popular intervention types in "Instituto Argentino de Diagnostico y Tratamiento" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lazertinib" (2 trials), "Abemaciclib" (1 trials), "Amivantamab" (1 trials), "Amivantamab Intravenous" (1 trials) and "Amivantamab Subcutaneous and Co-Formulated with Recombinant Human Hyaluronidase (SC CF)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Argentino de Diagnostico y Tratamiento" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Argentino de Diagnostico y Tratamiento". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Instituto Argentino de Diagnostico y Tratamiento, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Argentino de Diagnostico y Tratamiento, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".